Loading...
Docoh

Rockwell Medical (RMTI)

Employees
Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary
ESG framework mentions
In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On May 9, 2022, Rockwell Medical, Inc. (the “Company”) held its 2022 Annual Meeting of the Stockholders (the “Annual Meeting”). The following matters were submitted to a vote of the stockholders at the Annual Meeting and the voting results were as follows:

Proposal One: To elect the Class I director to serve for a three-year term expiring at the 2025 annual meeting of stockholders and until his successor has been duly elected and qualified.

ForAgainstAbstainBroker Non-Votes
Allen Nissenson, M.D.24,041,6382,393,357528,61735,799,968


Proposal Two: To approve, on an advisory basis, the compensation of the Company's named executive officers.

ForAgainstAbstainBroker Non-Votes
21,176,3115,154,232633,06935,799,968

Proposal Three: To ratify the selection of Marcum LLP as the Company’s independent registered public accounting firm for 2022.

ForAgainstAbstain
59,196,0222,231,4881,336,070

Proposal Four: To approve and adopt an amendment to the Company’s Certificate of Incorporation to effect a reverse stock split of the Company’s common stock with no change to the number of authorized shares of the Company’s common stock.

ForAgainstAbstain
51,696,75510,648,535418,290

Proposal Five: The proposal to approve and adopt amendments to the Company’s Certificate of Incorporation to (a) increase the number of authorized shares of the Company’s common stock from 170,000,000 shares to 340,000,000 shares and (b) effect a reverse stock split of the Company’s common stock with a 55 percent decrease to the number of authorized shares of the Company’s common stock was withdrawn because the Company’s stockholders approved and adopted Proposal Four as noted above.

Proposal Six: To approve an amendment and restatement of the Rockwell Medical, Inc. 2018 Long Term Incentive Plan to increase the number of shares reserved for issuance thereunder by 5,000,000 shares.

ForAgainstAbstainBroker Non-Votes
19,769,4456,967,282226,88535,799,968